COVID-19SARS-CoV-2DRUG allergySKIN biopsyBackground: During the height of the SARS CoV-2 (severe acutre respiratory syndrome coronavirus disease 2019 [COVID 19]) pandemic, there have been numerous case reports of cutaneous reactions shortly after COVID-19 vaccine admi...
LOS ANGELES, June 1 (Xinhua) -- A new study funded by the U.S. National Institutes of Health has found that people with food allergies are less likely to become infected with COVID-19 than people without them. The new study, published Wednesday in The Journal of Allergy and Clinical Imm...
up to 13% of infections occurred for mothers with gestations <13 weeks [43]. In the US, ~5–9% of women with COVID-19 were identified to be pregnant [33,44]. Tug et al. found more severe illness among pregnancies after 20 weeks gestational...
Several promising COVID-19 antivirals are currently in development, according to Anthony Fauci, MD, chief medical advisor to President Biden and director of the National Institute of Allergy and Infectious Diseases. (Photo courtesy of C-SPAN livestream) Also at the briefing, Anthony Fauci, MD, ...
SARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIH Almost a third (32 of every 100) of older adults infected with COVID-19 in 2020 developed at least one new condition that required medical attention in the months aft...
COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production. Here we develop three protein arrays to measure IgG autoantibodies associated with connective tissue diseases, anti-cytokine a
The COVID-19 pandemic has become a serious problem today, with its prevalence increasing every day The SARS-CoV-2 main protease (MPro) is a promising therapeutic target to inhibit replicating and spreading the virus that causes COVID-19 ... D Ramadhan,TM Fakih,A Arfan - 《Borneo Journal...
In response, Fauci, the director of the National Institute of Allergy and Infectious Diseases, said there is no CDC guidance on what to do when groups of people who have received both vaccine doses want to get together. "But I believe that's going to change," Fauci said. "We're talkin...
The new coronavirus disease 2019 (COVID-19) has been emerged as a rapidly spreading pandemic. The disease is thought to spread mainly from person-to-person through respiratory droplets produced when an infected person coughs, sneezes, or talks. The pathogen of COVID-19 is the severe acute res...
Retos de la COVID-19 Review / Artículo de Revisión SARS-CoV-2: a new threat SARS-CoV-2: una nueva amenaza VALIDA project: Validation of allergy in vitro diagnostics assays (Tools and recommendations for the assessment of in vitro tests in the diagnosis of allergy) Proyecto VALIDA...